Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Return on Assets (2017 - 2025)

Historic Return on Assets for Vistagen Therapeutics (VTGN) over the last 12 years, with Q4 2025 value amounting to 0.92%.

  • Vistagen Therapeutics' Return on Assets fell 4300.0% to 0.92% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.92%, marking a year-over-year decrease of 4300.0%. This contributed to the annual value of 0.49% for FY2025, which is 900.0% down from last year.
  • Per Vistagen Therapeutics' latest filing, its Return on Assets stood at 0.92% for Q4 2025, which was down 4300.0% from 0.83% recorded in Q3 2025.
  • In the past 5 years, Vistagen Therapeutics' Return on Assets ranged from a high of 0.16% in Q1 2021 and a low of 2.57% during Q2 2023
  • Its 5-year average for Return on Assets is 0.83%, with a median of 0.58% in 2025.
  • Per our database at Business Quant, Vistagen Therapeutics' Return on Assets skyrocketed by 35800bps in 2021 and then tumbled by -17500bps in 2023.
  • Quarter analysis of 5 years shows Vistagen Therapeutics' Return on Assets stood at 0.39% in 2021, then tumbled by -364bps to 1.81% in 2022, then skyrocketed by 80bps to 0.37% in 2023, then tumbled by -31bps to 0.49% in 2024, then crashed by -89bps to 0.92% in 2025.
  • Its last three reported values are 0.92% in Q4 2025, 0.83% for Q3 2025, and 0.73% during Q2 2025.